Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
sulfate de terbutaline 2,5 mg/5 mL, perfusion intraveineuse |
Is a |
False |
Terbutaline sulfate |
Inferred relationship |
Some |
|
Terbutaline sulfate 5 mg oral tablet |
Is a |
False |
Terbutaline sulfate |
Inferred relationship |
Some |
|
sulfate de terbutaline 500 microgrammes/1 mL, pour injection |
Is a |
False |
Terbutaline sulfate |
Inferred relationship |
Some |
|
Terbutaline sulfate 7.5mg m/r tablet |
Is a |
False |
Terbutaline sulfate |
Inferred relationship |
Some |
|
Terbutaline sulfate 1.5mg/5mL syrup |
Is a |
False |
Terbutaline sulfate |
Inferred relationship |
Some |
|
Inhaled terbutaline |
Is a |
False |
Terbutaline sulfate |
Inferred relationship |
Some |
|
Terbutaline sulfate [respiratoty use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Terbutaline sulfate |
Inferred relationship |
Some |
|
sulfate de terbutaline 2,5 mg/5 mL, perfusion intraveineuse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Terbutaline sulfate |
Inferred relationship |
Some |
|
Terbutaline sulfate 200mg/20mL nebulizer solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Terbutaline sulfate |
Inferred relationship |
Some |
|
Terbutaline sulfate 500micrograms breath-actuated dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Terbutaline sulfate |
Inferred relationship |
Some |
|
Terbutaline sulfate 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Terbutaline sulfate |
Inferred relationship |
Some |
|
sulfate de terbutaline 500 microgrammes/1 mL, pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Terbutaline sulfate |
Inferred relationship |
Some |
|
Terbutaline sulfate 250micrograms inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Terbutaline sulfate |
Inferred relationship |
Some |
|
Terbutaline sulfate 250micrograms spacer inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Terbutaline sulfate |
Inferred relationship |
Some |
|
Terbutaline sulfate 5mg/2mL nebulization unit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Terbutaline sulfate |
Inferred relationship |
Some |
|
Terbutaline sulfate 7.5mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Terbutaline sulfate |
Inferred relationship |
Some |
|
Terbutaline sulfate 1.5mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Terbutaline sulfate |
Inferred relationship |
Some |
|
Terbutaline sulfate [myometrial relaxant] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Terbutaline sulfate |
Inferred relationship |
Some |
|
Terbutaline sulfate 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Terbutaline sulfate |
Inferred relationship |
Some |
|
Product containing precisely terbutaline sulfate 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Terbutaline sulfate |
Inferred relationship |
Some |
|
Terbutaline sulfate 0.2mg/inh aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Terbutaline sulfate |
Inferred relationship |
Some |
|
Terbutaline sulfate 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Terbutaline sulfate |
Inferred relationship |
Some |
1 |
Terbutaline sulfate 5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Terbutaline sulfate |
Inferred relationship |
Some |
1 |
Terbutaline sulfate 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Terbutaline sulfate |
Inferred relationship |
Some |
1 |
Terbutaline sulfate 2.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Terbutaline sulfate |
Inferred relationship |
Some |
1 |
Terbutaline sulfate 7.5 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Terbutaline sulfate |
Inferred relationship |
Some |
1 |
Terbutaline sulfate 7.5 mg prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Terbutaline sulfate |
Inferred relationship |
Some |
1 |
Terbutaline sulfate 5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Terbutaline sulfate |
Inferred relationship |
Some |
1 |
Terbutaline sulfate 2.5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Terbutaline sulfate |
Inferred relationship |
Some |
1 |
Terbutaline sulfate 300 microgram/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Terbutaline sulfate |
Inferred relationship |
Some |
1 |
Terbutaline sulfate 300 microgram/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Terbutaline sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely terbutaline sulfate 500 microgram/1 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Terbutaline sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely terbutaline sulfate 500 microgram/1 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Terbutaline sulfate |
Inferred relationship |
Some |
1 |
Terbutaline sulfate 500 microgram/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Terbutaline sulfate |
Inferred relationship |
Some |
1 |
Terbutaline sulfate 500 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Terbutaline sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely terbutaline sulfate 2.5 milligram/5 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Terbutaline sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely terbutaline sulfate 2.5 milligram/5 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Terbutaline sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely terbutaline sulfate 500 microgram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Terbutaline sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely terbutaline sulfate 500 microgram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Terbutaline sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely terbutaline sulfate 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Terbutaline sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely terbutaline sulfate 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Terbutaline sulfate |
Inferred relationship |
Some |
1 |
Terbutaline sulfate 200 microgram/mL solution for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Terbutaline sulfate |
Inferred relationship |
Some |
1 |
Terbutaline sulfate 200 microgram/mL solution for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Terbutaline sulfate |
Inferred relationship |
Some |
1 |
Terbutaline sulfate 10 mg/mL solution for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Terbutaline sulfate |
Inferred relationship |
Some |
1 |
Terbutaline sulfate 10 mg/mL solution for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Terbutaline sulfate |
Inferred relationship |
Some |
1 |
Terbutaline sulfate 2.5 mg/mL solution for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Terbutaline sulfate |
Inferred relationship |
Some |
1 |
Terbutaline sulfate 2.5 mg/mL solution for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Terbutaline sulfate |
Inferred relationship |
Some |
1 |
Ambroxol hydrochloride 3 mg/mL and guaifenesin 10 mg/mL and terbutaline sulfate 250 microgram/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Terbutaline sulfate |
Inferred relationship |
Some |
1 |
Ambroxol hydrochloride 3 mg/mL and guaifenesin 10 mg/mL and terbutaline sulfate 250 microgram/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Terbutaline sulfate |
Inferred relationship |
Some |
1 |